Seminars in Nephrology
Volume 29, Issue 4 , Pages 349-359, July 2009

Update on Childhood Urinary Tract Infection and Vesicoureteral Reflux

  • Lorraine E. Bell, MDCM

      Affiliations

    • Department of Pediatrics, Division of Pediatric Nephrology, McGill University Health Centre, Montreal, Quebec, Canada
  • ,
  • Tej K. Mattoo, MD, DCH, FRCP (UK)

      Affiliations

    • Division of Pediatric Nephrology & Hypertension, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI
    • Corresponding Author InformationAddress reprint requests to Tej K. Mattoo, MD, DCH, FRCP (UK), Children's Hospital of Michigan, 3901 Beaubien Blvd, Detroit, MI 48201

Summary 

Urinary tract infection (UTI) is a leading cause of serious bacterial infection in young children. Vesicoureteral reflux (VUR), a common pediatric urologic disorder, is believed to predispose to UTI, and both are associated with renal scarring. The complex interaction of bacterial virulence factors and host defense mechanisms influence renal damage. However, some renal parenchymal abnormalities associated with VUR are noninfectious in origin. Long-term, renal parenchymal injury may be associated with hypertension, pregnancy complications, proteinuria, and renal insufficiency. Optimal management of VUR and UTI is controversial because of the paucity of appropriate randomized controlled trials; there is a need for well-designed studies. The recently launched Randomized Intervention for children with VesicoUreteral Reflux (RIVUR) study hopefully will provide insight into the role of antimicrobial prophylaxis of UTI in children with VUR.

Keywords: Urinary tract infection, vesicoureteral reflux, antimicrobial prophylaxis, chronic kidney disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Mattoo is supported by the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases.

PII: S0270-9295(09)00048-5

doi:10.1016/j.semnephrol.2009.03.011

Seminars in Nephrology
Volume 29, Issue 4 , Pages 349-359, July 2009